Literature DB >> 23256547

Mitochondrial COX2 G7598A mutation may have a modifying role in the phenotypic manifestation of aminoglycoside antibiotic-induced deafness associated with 12S rRNA A1555G mutation in a Han Chinese pedigree.

Tianbin Chen1, Qicai Liu, Ling Jiang, Can Liu, Qishui Ou.   

Abstract

Recent studies suggest that certain mitochondrial haplogroup markers and some specific variants in mitochondrial haplogroup may also influence the phenotypic expression of particular mitochondrial disorders. In this report, the clinical, genetic, and molecular characterization were identified in a Chinese pedigree with the aminoglycoside antibiotic (AmAn)-induced deafness and nonsyndromic hearing loss (NSHL). The pathogenic gene responsible for this hereditary NSHL pedigree was determined by Microarray chip, which possessed the nine NSHL hot-spot mutations, including GJB2 (35delG, 176dell6bp, 235de1C, and 299delAT), GJB3 (538C>T), SLC26A4 (IVS7-2A>G and 2168A>G), and mitochondrial DNA (mtDNA) 12S rRNA (C1494T and A1555G). Only the homoplasmic A1555G mutation was detected, which was confirmed by direct sequencing. Also, real-time amplification refractory mutation system quantitative polymerase chain reaction methodology was performed to calculate the A1555G mutation load. The proband's complete mtDNA genome were amplified and direct sequencing was performed to determine the mitochondrial haplogroup and private mutations. The proband's mitochondrial haplogroup belonges to M7b1 and a private mutation MTCOX2 G7598A (p.Ala 5 Thr) is found. Phylogenetic analysis of COX2 polypeptide sequences demonstrates that the alanine residue is relatively conserved, but owing to the missense mutation (p.Ala 5 Thr), its side chain hydrophobicity will be changed, and what is more, as it is adjacent to a glutamine residue, which is highly conserved and hydrophilic, in an evolutionary stable domain; G7598A (p.Ala 5 Thr) may alter the protein secondary structure and physiological function of COX2 and, thus, aggravate the mitochondrial dysfunction conferred by the A1555G mutation. Furthermore, the G7598A mutation is absent in 100 unrelated healthy controls; therefore, G7598A (p.Ala 5 Thr) in the mitochondrial haplogoup M7b1 may have a modifying role, enhancing its penetrance and severity, in the AmAn-induced deafness and NSHL associated with 12S rRNA A1555G mutation in the Han Chinese pedigree.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23256547      PMCID: PMC3552164          DOI: 10.1089/gtmb.2012.0251

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  36 in total

Review 1.  Mitochondrial DNA and disease.

Authors:  Salvatore Dimauro; Guido Davidzon
Journal:  Ann Med       Date:  2005       Impact factor: 4.709

Review 2.  Genetic factors in aminoglycoside toxicity.

Authors:  Nathan Fischel-Ghodsian
Journal:  Pharmacogenomics       Date:  2005-01       Impact factor: 2.533

3.  A novel mtDNA ND6 gene mutation associated with LHON in a Caucasian family.

Authors:  Sergey I Zhadanov; Vasily V Atamanov; Nikolay I Zhadanov; Oleg V Oleinikov; Ludmila P Osipova; Theodore G Schurr
Journal:  Biochem Biophys Res Commun       Date:  2005-07-15       Impact factor: 3.575

4.  Clinical evaluation and mitochondrial DNA sequence analysis in two Chinese families with aminoglycoside-induced and non-syndromic hearing loss.

Authors:  Lidong Zhao; Qiuju Wang; Yaping Qian; Ronghua Li; Juayng Cao; Laura Christine Hart; Suoqiang Zhai; Dongyi Han; Wie-Yen Young; Min-Xin Guan
Journal:  Biochem Biophys Res Commun       Date:  2005-10-28       Impact factor: 3.575

5.  Extremely low penetrance of hearing loss in four Chinese families with the mitochondrial 12S rRNA A1555G mutation.

Authors:  Wie-Yen Young; Lidong Zhao; Yaping Qian; Qiuju Wang; Ning Li; John H Greinwald; Min-Xin Guan
Journal:  Biochem Biophys Res Commun       Date:  2005-03-25       Impact factor: 3.575

6.  Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness.

Authors:  T R Prezant; J V Agapian; M C Bohlman; X Bu; S Oztas; W Q Qiu; K S Arnos; G A Cortopassi; L Jaber; J I Rotter
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

7.  Biochemical evidence for nuclear gene involvement in phenotype of non-syndromic deafness associated with mitochondrial 12S rRNA mutation.

Authors:  M X Guan; N Fischel-Ghodsian; G Attardi
Journal:  Hum Mol Genet       Date:  1996-07       Impact factor: 6.150

8.  Detection and quantification of heteroplasmic mutant mitochondrial DNA by real-time amplification refractory mutation system quantitative PCR analysis: a single-step approach.

Authors:  Ren-Kui Bai; Lee-Jun C Wong
Journal:  Clin Chem       Date:  2004-04-08       Impact factor: 8.327

9.  The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 A.

Authors:  T Tsukihara; H Aoyama; E Yamashita; T Tomizaki; H Yamaguchi; K Shinzawa-Itoh; R Nakashima; R Yaono; S Yoshikawa
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

10.  Mitochondrial DNA mutations in patients with postlingual, nonsyndromic hearing impairment.

Authors:  Howard T Jacobs; Timothy P Hutchin; Timo Käppi; Greta Gillies; Kia Minkkinen; John Walker; Karen Thompson; Anja T Rovio; Massimo Carella; Salvatore Melchionda; Leopoldo Zelante; Paolo Gasparini; Ilmari Pyykkö; Zahid H Shah; Massimo Zeviani; Robert F Mueller
Journal:  Eur J Hum Genet       Date:  2005-01       Impact factor: 4.246

View more
  2 in total

1.  Screening for deafness-associated mitochondrial 12S rRNA mutations by using a multiplex allele-specific PCR method.

Authors:  Yu Ding; Jianyong Lang; Junkun Zhang; Jianfeng Xu; Xiaojiang Lin; Xiangyu Lou; Hui Zheng; Lei Huai
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

2.  Genetic testing involving 100 common mutations for antenatal diagnosis of hereditary hearing loss in Chongqing, China.

Authors:  Hua Hu; Peng Zhou; Jiayan Wu; Wei Lei; Yang Wang; Ying Yang; Hailiang Liu
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.